Rating History for Windtree Therapeutics (WINT) by Oppenheimer

More Stocks Rated by Oppenheimer | Latest Ratings for WINT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/16/2022 Leland Gershell Maintain Outperform
(N/A)		 2.00
(3.00)		  
 		   Details